CorMedix Inc. to Present at 28th Annual ROTH Conference

 

Bedminster, NJ – March 10, 2016 – CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced today that CorMedix Chief Executive Officer Randy Milby will present to investors at the 28th Annual ROTH Conference on March 15, 2016, at 8:00 a.m. Pacific Time at the Ritz-Carlton, Laguna Niguel in Dana Point, California.

 

One-on-one meetings with Mr. Milby can be scheduled through ROTH or through CorMedix’s Investor Relations: Maureen McEnroe, (914) 588-1873; or Tiberend Strategic Advisors (contacts below).

 

To access a live webcast or replay of the formal presentation, visit:

http://wsw.com/webcast/roth30/crmd.

 

For Investors & Media:

CorMedix

Maureen McEnroe, CFA: mmcenroe@machealthcare.com;  (914) 588-1873

 

Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D.: jdrumm@tiberend.com; (212) 375-2664

Janine McCargo: jmccargo@tiberend.com; (646) 604-5150